Inhibition of hepatitis C virus replication in vitro by xanthohumol, a natural product present in hops

Planta Medica

Volumn 80, Issue 2-3, 2014, Pages 171-176

  Lou, Sai ^a   Zheng, Yi Min ^b   Liu, Shan Lu ^b   Qiu, Jianming ^c   Han, Qunying ^a   Li, Na ^a   Zhu, Qianqian ^a   Zhang, Pingping ^a   Yang, Cuiling ^a   Liu, Zhengwen ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b University of Missouri   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabaceae; HCV cell culture; hepatitis C virus; Humulus lupulus; xanthohumol

Indexed keywords

ANTIVIRAL AGENTS; CELLS, CULTURED; FLAVONOIDS; HEPACIVIRUS; HUMANS; HUMULUS; PROPIOPHENONES; VIRUS REPLICATION;

EID: 84894272091     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1360172     Document Type: Article

References (39)

1. Lavanchy D. The global burden of hepatitis C. Liver Int: 2009; 29 01 74 81
2. Ghany M. G., Strader D. B., Thomas D. L., Seeff L. B. American Association for the Study of Liver Diseases Diagnosis, management, and treatment of hepatitis C: an update. Hepatology: 2009; 49 1335 1374
3. Fried M. W., Shiffman M. L., Reddy K. R., Smith C., Marinos G., Gonçales F. L. jr., Häussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med: 2002; 347 975 982
4. McHutchison J. G., Lawitz E. J., Shiffman M. L., Muir A. J., Galler G. W., McCone J., Nyberg L. M., Lee W. M., Ghalib R. H., Schiff E. R., Galati J. S., Bacon B. R., Davis M. N., Mukhopadhyay P., Koury K., Noviello S., Pedicone L. D., Brass C. A., Albrecht J. K., Sulkowski M. S. IDEAL Study Team Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection. N Engl J Med: 2009; 361 580 593
5. Ferenci P., Laferl H., Scherzer T. M., Maieron A., Hofer H., Stauber R., Gschwantler M., Brunner H., Wenisch C., Bischof M., Strasser M., Datz C., Vogel W., Löschenberger K., Steindl-Munda P. Austrian Hepatitis Study Group Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response. Gastroenterology: 2010; 138 503 512 512.e1
6. Lee S. S., Roberts S. K., Berak H., Dusheiko G. M., Harley H. A., Gane E. J., Husa P., Horsmans Y. J., Hadziyannis S. J., Jenny Heathcote E., Messinger D., Tatsch F., Han K. H., Ferenci P. Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients. Liver Int: 2012; 32 1270 1277
7. Poordad F., McCone J. jr., Bacon B. R., Bruno S., Manns M. P., Sulkowski M. S., Jacobson I. M., Reddy K. R., Goodman Z. D., Boparai N., DiNubile M. J., Sniukiene V., Brass C. A., Albrecht J. K., Bronowicki J. P. SPRINT-2 Investigators Boceprevir for untreated chronic HCV genotype 1 infection. N Engl J Med: 2011; 364 1195 1206
8. Jacobson I. M., McHutchison J. G., Dusheiko G., Di Bisceglie A. M., Reddy K. R., Bzowej N. H., Marcellin P., Muir A. J., Ferenci P., Flisiak R., George J., Rizzetto M., Shouval D., Sola R., Terg R. A., Yoshida E. M., Adda N., Bengtsson L., Sankoh A. J., Kieffer T. L., George S., Kauffman R. S., Zeuzem S. ADVANCE Study Team Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl J Med: 2011; 364 2405 2416
9. Halfon P., Locarnini S. Hepatitis C virus resistance to protease inhibitors. J Hepatol: 2011; 55 192 206
10. Stevens J. F., Taylor A. W., Deinzer M. L. Quantitative analysis of xanthohumol and related prenylflavonoids in hops and beer by liquid chromatography-tandem mass spectrometry. J Chromatogr A: 1999; 832 97 107 (Pubitemid 29073728)
11. Gerhauser C., Alt A., Heiss E., Gamal-Eldeen A., Klimo K., Knauft J., Neumann I., Scherf H. R., Frank N., Bartsch H., Becker H. Cancer chemopreventive activity of Xanthohumol, a natural product derived from hop. Mol Cancer Ther: 2002; 1 959 969
12. Stevens J. F., Page J. E. Xanthohumol and related prenylflavonoids from hops and beer: to your good health! Phytochemistry: 2004; 65 1317 1330 (Pubitemid 38844716)
13. Kuete V., Ngameni B., Wiench B., Krusche B., Horwedel C., Ngadjui B. T., Efferth T. Cytotoxicity and mode of action of four naturally occuring flavonoids from the genus Dorstenia: gancaonin Q, 4-hydroxylonchocarpin, 6-prenylapigenin, and 6,8-diprenyleriodictyol. Planta Med: 2011; 77 1984 1989
14. Zanoli P., Zavatti M. Pharmacognostic and pharmacological profile of Humulus lupulus L. J Ethnopharmacol: 2008; 116 383 396 (Pubitemid 351335198)
15. Cho Y. C., Kim H. J., Kim Y. J., Lee K. Y., Choi H. J., Lee I. S., Kang B. Y. Differential anti-inflammatory pathway by xanthohumol in IFN-gamma and LPS-activated macrophages. Int Immunopharmacol: 2008; 8 567 573
16. Peluso M. R., Miranda C. L., Hobbs D. J., Proteau R. R., Stevens J. F. Xanthohumol and related prenylated flavonoids inhibit inflammatory cytokine production in LPS-activated THP-1 monocytes: structure-activity relationships and in silico binding to myeloid differentiation protein-2 (MD-2). Planta Med: 2010; 76 1536 1543
17. Stevens J. F., Miranda C. L., Frei B., Buhler D. R. Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the alpha, beta-unsaturated keto functionality of 2′-hydroxychalcones as a novel antioxidant pharmacophore. Chem Res Toxicol: 2003; 16 1277 1286 (Pubitemid 37315217)
18. Miranda C. L., Stevens J. F., Ivanov V., McCall M., Frei B., Deinzer M. L., Buhler D. R. Antioxidant and prooxidant actions of prenylated and nonprenylated chalcones and flavanones in vitro. J Agric Food Chem: 2000; 48 3876 3884
19. Tabata N., Ito M., Tomoda H., Omura S. Xanthohumols, diacylglycerol acyltransferase inhibitors, from Humulus lupulus. Phytochemistry: 1997; 46 683 687 (Pubitemid 27483829)
20. Casaschi A., Maiyoh G. K., Rubio B. K., Li R. W., Adeli K., Theriault A. G. The chalcone xanthohumol inhibits triglyceride and apolipoprotein B secretion in HepG2 cells. J Nutr: 2004; 134 1340 1346 (Pubitemid 38720704)
21. Buckwold V. E., Wilson R. J., Nalca A., Beer B. B., Voss T. G., Turpin J. A., Buckheit R. W. 3rd, Wei J., Wenzel-Mathers M., Walton E. M., Smith R. J., Pallansch M., Ward P., Wells J., Chuvala L., Sloane S., Paulman R., Russell J., Hartman T., Ptak R. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res: 2004; 61 57 62 (Pubitemid 37508529)
22. Cos P., Maes L., Vlietinck A., Pieters L. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection - an update (1998-2007). Planta Med: 2008; 74 1323 1337
23. Zhang N., Liu Z., Han Q., Chen J., Lou S., Qiu J., Zhang G. Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: comparisons with ribavirin and interferon-alpha and implications for the development of anti-hepatitis C virus agents. Eur J Pharm Sci: 2009; 38 332 340
24. Zhang N., Liu Z., Han Q., Chen J., Lv Y. Xanthohumol enhances antiviral effect of interferon alpha-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus. Phytomedicine: 2010; 17 310 316
25. Yang M., Li N., Li F., Zhu Q., Liu X., Han Q., Wang Y., Chen Y., Zeng X., Lv Y., Zhang P., Yang C., Liu Z. Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri. Int Immunopharmacol: 2013; 16 466 474
26. Herker E., Harris C., Hernandez C., Carpentier A., Kaehlcke K., Rosenberg A. R., Farese R. V. jr., Ott M. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat Med: 2010; 16 1295 1298
27. Nahmias Y., Goldwasser J., Casali M., van Poll D., Wakita T., Chung R. T., Yarmush M. L. Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin. Hepatology: 2008; 47 1437 1445 (Pubitemid 351702727)
28. De Clercq E. The race for interferon-free HCV therapies: a snapshot by the spring of 2012. Rev Med Virol: 2012; 22 392 411
29. Chatel-Chaix L., Germain M. A., Götte M., Lamarre D. Direct-acting and host-targeting HCV inhibitors: current and future directions. Curr Opin Virol: 2012; 2 588 598
30. Dorn C., Kraus B., Motyl M., Weiss T. S., Gehrig M., Schölmerich J., Heilmann J., Hellerbrand C. Xanthohumol, a chalcone derived from hops, inhibits hepatic inflammation and fibrosis. Mol Nutr Food Res: 2010; 54 02 S205 S213
31. Dorn C., Heilmann J., Hellerbrand C. Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis. Int J Clin Exp Pathol: 2012; 5 29 36
32. Nozawa H. Xanthohumol, the chalcone from beer hops (Humulus lupulus L.), is the ligand for farnesoid X receptor and ameliorates lipid and glucose metabolism in KK-A(y) mice. Biochem Biophys Res Commun: 2005; 336 754 761 (Pubitemid 41338333)
33. Thomopoulos K. C., Theocharis G. J., Tsamantas A. C., Siagris D., Dimitropoulou D., Gogos C. A., Labropoulou-Karatza C. Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol: 2005; 17 149 153 (Pubitemid 40349527)
34. Mehta S. H., Brancati F. L., Sulkowski M. S., Strathdee S. A., Szklo M., Thomas D. L. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med: 2000; 133 592 599
35. Dorn C., Bataille F., Gaebele E., Heilmann J., Hellerbrand C. Xanthohumol feeding does not impair organ function and homoeostasis in mice. Food Chem Toxicol: 2010; 48 1890 1897
36. Hussong R., Frank N., Knauft J., Ittrich C., Owen R., Becker H., Gerhäuser C. A safety study of oral xanthohumol administration and its influence on fertility in Sprague Dawley rats. Mol Nutr Food Res: 2005; 49 861 867 (Pubitemid 41411571)
37. Lindenbach B. D., Evans M. J., Syder A. J., Wölk B., Tellinghuisen T. L., Liu C. C., Maruyama T., Hynes R. O., Burton D. R., McKeating J. A., Rice C. Complete replication of hepatitis C virus in cell culture. Science: 2005; 309 623 626 (Pubitemid 41033648)
38. Lou S., Xu B., Huang Q., Zhi N., Cheng F., Wong S., Brown K., Delwart E., Liu Z., Qiu J. Molecular characterization of the newly identified human parvovirus 4 in the family Parvoviridae. Virology: 2012; 422 59 69
39. Guan W., Wong S., Zhi N., Qiu J. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus. J Virol: 2009; 83 9541 9553